Association Between BMI and the Efficacy and Safety of CDK4/6 Inhibitors in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Propensity Score Matched Cohort Study (CAMELIA)

Min Tian, Yijia Hua, Qian Liu, Nan Jin, Xinyu Wu, Kun Wang, Min Yan, Tao Sun, Chunfang Hao, Yanxia Zhao, Wei Li, Xiang Huang, Yongmei Yin
MedComm - Oncology · Wiley · 2026-09-24 · DOI: 10.1002/mog2.70096

Аннотация

MedComm – Oncology, Volume 5, Issue 4, December 2026.

Читать у издателя →

Похожие статьи